Several authors have reported successful PML treatment using immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD1), but whether ICIs targeting other proteins such as programmed death-ligand 1 (PD-L) could also treat PML is unknown (2). This evidence concerns the gene PDCD1 and progressive multifocal leukoencephalopathy.